The future of patent-based injunctions in doubt in India after explosive Delhi High Court ruling

Bayer has failed to block an Indian generic rival from exporting an erectile dysfunction drug in a case that one observer says breaks new ground in considering how to weigh public interest issues relating to the grant or not of patent-based…

Get unlimited access to all IAM content